Nano Dimension appoints Dr. Yoav Nissan-Cohen as Chairman of the Board
As part of broader Board governance structure and functionality updates, Yoav Stern will remain as CEO, and Col. (Ret.) Channa Caspi has stepped down
Nano Dimension’s Board of Directors has appointed Dr. Yoav Nissan-Cohen as Chairman of the Board, effective immediately. Yoav Stern will continue as the company’s CEO and Director. In addition to this, Col. (Ret.) Channa Caspi has stepped down from the Board due to personal medical circumstances – reducing the Board from nine to eight directors.
Dr. Nissan-Cohen joined Nano Dimension’s Board of Directors in December 2022. His career covers almost 40 years of scientific research, technology development, and executive management in the high-tech industry. He started his career as a research scientist in the General Electric R&D Center, in New York. He holds a Ph.D. degree in Physics from the Hebrew University of Jerusalem.
In 1988 Dr. Nissan-Cohen joined National Semiconductor as a technology development manager, and in 1993 he was one of the founders of Tower Semiconductor (Nasdaq: TSEM), where he served as a CEO, took the company public in NASDAQ, and built a $1.5B advanced semiconductor facility.
Dr. Nissan-Cohen is the Chairman of TeraCyte, a biotechnology company that developed a platform for high throughput temporal analysis of live single-cells, with breakthrough applications for research, discovery, and development of new drugs and therapies.
In 2002 he joined Pitango as a venture partner, and in 2004 he came back to his entrepreneurial origin and took the Chairman and CEO position in Amimon, a semiconductor company that provides the only solution for zero-latency wireless camera link for various applications such as operating rooms in hospitals and TV and film productions.
Dr. Nissan-Cohen is also the Chairman of Visionlab, a company specializing in advanced vision-based solutions for industrial and military applications. He founded and managed several other companies, including a joint venture with Emmy Award-winning directors to bring game-changing solutions to film and TV productions. Currently, Dr. Nissan-Cohen also serves as an executive board member in Weebit, a semiconductor company developing a new class of semiconductor memories.
“We’ve considered feedback from our shareholders, as well as the recommendations of governance experts, ISS and Glass Lewis, and have decided to make changes to our Board that we believe will evolve and enhance our corporate governance. As we move into the next phase of executing our strategic plan, separating the Chairman and CEO roles is an important step in strengthening Nano’s governance practices and increasing independent oversight by the Board. We remain committed to maintaining the right balance of strong and consistent leadership to guide Nano in the years ahead, while delivering value for our shareholders,” said Yoav Stern, CEO of Nano Dimension. “On a personal level, it is a unique opportunity for me to be able to work closely with Dr. Nissan-Cohen, gaining from his vast experience and unique business and leadership vision. I look forward to learning from him and to excel together with him for the betterment of Nano Dimension, its shareholders, and all other relevant constituencies.”
“I am confident in Nano, and I look forward to working with Yoav, my fellow Board members, and the management team as we continue to execute Nano’s strategy and drive value for shareholders,” said Dr. Nissan-Cohen.
“Nano, and me personally, are sad to part ways with Channy. She has consistently made impactful contributions to Nano and provided expert guidance to our teams with her personal and professional insightful input. On behalf of the entire Board and management team, I would like to wish Channy a speedy recovery and return back to full healthy functionality, and we are all highly thankful for her valuable wisdom and dedicated service. We and me individually were very fortunate to have her as a unique and integral part of us,” added Mr. Stern.
